Identificer potentielle risici, uoverensstemmelser og advarselstegn på tværs af alle udbudsdokumenter. Få en detaljeret risikorapport med alvorlighedsgrader og anbefalinger til afhjælpning.
Log indFå en AI-drevet vinderstrategi skræddersyet til dette udbud. Inkluderer sandsynlighedsscore for at vinde, vigtige muligheder og udfordringer, anbefalede fokusområder for tilbuddet, indsigt i konkurrencepositionering og handlingsrettede anbefalinger for at maksimere dine chancer.
Log indOpgrader for at se, hvilke virksomheder der sandsynligvis vil afgive tilbud på dette udbud, baseret på historiske indkøbsdata.
Log ind23 krav på tværs af 5 kategorier
Tilmeld dig for at se komplette krav og analyser
10 dokumenter tilgængelige med AI-resuméer
Estonia’s Tartu University Hospital seeks suppliers for mandatory blood components and immunohematology analyses, requiring only that bidders submit an unsigned offer in Word (Annex 1), include the participation form (Annex 4-III) and, if applicable, joint-bid or signing-authority letters—no technical, quality or financial qualification hurdles are stated in this compliance notice—so any blood-product distributor or lab that can deliver the listed items and complete the simple paperwork should consider bidding.
Tartu University Hospital seeks a single supplier (no lot division) to deliver annually ~50 filtered extended-phenotype red-cell units (≥3-week shelf life, +2–6 °C, 3-day delivery) and ~30 cryoprecipitate units (≥12-month shelf life, –18 to –25 °C, same-day delivery), perform all listed immunohematology tests and 24/7 consultation, maintain permanent stock, and provide electronic dispatch papers/certificates on request—cold-chain capacity, blood-bank accreditation and immediate availability are therefore mandatory.
This document is merely a participation-declaration form for the Tartu University Hospital’s blood-component and immuno-haematology-analysis tender, so it contains no mandatory technical requirements, no qualification criteria and no evaluation rules—suppliers must obtain the full tender dossier to decide whether to bid.
This is a 100% price-based procurement (no qualification filters stated) where the University of Tartu Hospital will simply pick the supplier offering the highest percentage discount off the national Health Insurance Fund’s official price list for blood components and immuno-haematology tests, so any firm already holding the required Estonian Health Board licences for blood products can bid and the only decisive factor is how big a discount they dare to quote.
This explanatory document merely introduces Tartu University Hospital’s open procurement for blood components and immuno-haematology analyses, states that suppliers must submit their qualification evidence electronically via the ESPD (European Single Procurement Document) system, but contains no mandatory technical, financial or exclusion criteria—companies therefore need to open the full e-tender files to decide whether to bid.
Tartu University Hospital seeks suppliers registered in the EU/EEA/WTO GPA area to deliver blood components and immunohematology tests for its blood centre under a single-lot framework contract, requiring full compliance with all RHAD conditions (mandatory), 3-month offer validity, and 7-day contract signing deadline.
This draft framework agreement for the supply of blood components and immunohematology analyses to Tartu University Hospital (mandatory compliance with Estonian Minister of Health Regulations 50/2016 & 51/2016 on quality and preparation of blood components) requires bidders to be licensed blood establishments able to deliver filtered extended-phenotype erythrocyte suspensions and pooled cryoprecipitate on a call-off basis; companies lacking a certified blood centre, valid CE-marked component specifications and 24 h delivery capability should not bid.
The attached “Lisa 3” is only the draft data-processing agreement that must be signed by any supplier to Tartu Ülikooli Kliinikum under the blood-component and immuno-haematology framework contract; it sets out GDPR duties (but contains no product specs, quantities, prices or award criteria) and is therefore not sufficient on its own for a bid/no-bid decision.
This document is merely a blank power-of-attorney template (Form II) that a tenderer must complete and attach to its offer so that the person signing the bid for “Blood components and immuno-haematological analyses” is duly authorised—no technical requirements, qualifications or evaluation criteria are stated here.
This document is merely a template for a joint-bidder power-of-attorney form; it contains no mandatory technical requirements, qualification thresholds or award criteria, so suppliers can only infer that if they plan to submit a joint offer for the Tartu University Hospital’s upcoming framework contract for blood components and immunohematology tests they must formally appoint one of their members to sign the bid and any resulting agreement.
Tilmeld dig for at se dokumentresuméer og analyser
Omfattende kvalitetsanalyse af dette udbud, der scorer juridisk overholdelse, klarhed, fuldstændighed, retfærdighed, praktisk anvendelighed, datakonsistens og bæredygtighed på en skala fra 0-100 med detaljeret opdeling og anbefalinger.
Log indHej! Jeg er din AI-assistent for dette udbud. Jeg kan hjælpe dig med at forstå krav, frister, berettigelseskriterier og give strategiske indsigter.
Intet kreditkort krævet